|
Vote and Deadlines
Newborn Screening Follow-up (I/LA27-P); Laboratory Documents: Development and Control; Approved Guideline—Fifth Edition (GP2-A5)
I/LA27-P—Newborn Screening Follow-up; Proposed Guideline I/LA27-P describes the basic principles, scope, and range of follow-up activities within the newborn screening system. It is intended for use by those involved in any aspect of follow-up, including healthcare providers, parents, and others concerned with the health and welfare of newborns. The deadline for the completed ballot for I/LA27-P to be received at the CLSI offices is 13 December 2005.
GP2-A5—Laboratory Documents: Development and Control; Approved Guideline—Fifth Edition This document presents the important components of writing and managing documents for the clinical laboratory, including descriptions of common and specific sections for inclusion. Appendixes provide examples of process and procedure documents for preexamination, examination, and postexamination laboratory activities. The deadline for the completed ballot for GP2-A5 to be received at the CLSI offices is 14 November 2005.
Second Notice
M2-A9—Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Ninth Edition This standard contains the current recommended methods for disk susceptibility testing, criteria for quality control testing, and updated tables for interpretive zone diameters. The deadline for the completed ballot for M2-A9 to be received at the CLSI offices is 18 October 2005.
M7-A7—Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Seventh Edition This document addresses reference methods for the determination of minimal inhibitory concentrations (MICs) of aerobic bacteria by broth macrodilution, broth microdilution, and agar dilution. The deadline for the completed ballot for M7-A7 to be received at the CLSI offices is 18 October 2005.
M100-S16—Performance Standards for Antimicrobial Susceptibility Testing; Sixteenth Informational Supplement This document provides updated tables for the Clinical and Laboratory Standards Institute (CLSI) antimicrobial susceptibility testing standards M2-A9 and M7-A7. The deadline for the completed ballot for M100-S16 to be received at the CLSI offices is 18 October 2005.
M39-A2—Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data; Approved Guideline—Second Edition This document describes methods for recording and analysis of antimicrobial susceptibility test data, consisting of cumulative and ongoing summaries of susceptibility patterns of clinically significant microorganisms. The deadline for the completed ballot for M39-A2 to be received at the CLSI offices is 18 October 2005.
M42-P—Methods for Antimicrobial Disk Susceptibility Testing of Bacteria Isolated From Aquatic Animals; Proposed Guideline M42-P provides the most up-to-date techniques for disk diffusion susceptibility testing of aquatic species isolates. This guideline includes quality control and quality assurance parameters for both fastidious and nonfastidious aquatic bacterial pathogens, protocols for data comparison between laboratories, and nonfastidious aquatic bacterial pathogen testing. The deadline for the completed ballot for M42-P to be received at the CLSI offices is 17 November 2005.
M49-P—Methods for Broth Dilution Susceptibility Testing of Bacteria Isolated From Aquatic Animals; Proposed Guideline A standardized broth dilution method for determining minimal inhibitory concentrations (MICs) of aquatic bacteria by broth micro- and macrodilution. This guideline includes quality control and quality assurance parameters for both fastidious and nonfastidious aquatic bacterial pathogens, protocols for data comparison between laboratories, and nonfastidious aquatic bacterial pathogen testing. The deadline for the completed ballot for M49-P to be received at the CLSI offices is 17 November 2005.
H56-P—Body Fluid Analysis for Cellular Composition; Proposed Guideline This guideline describes manual and automated methods to enumerate cellular components and to identify normal and abnormal elements. It also addresses additional studies that may be used for body fluid testing in the routine clinical laboratory. H56-P provides recommendations for collection and transport of body fluids, numeration and identification of cellular components, and guidance for qualitative and quantitative assessment of body fluid. The deadline for the completed ballot for H56-P to be received at the CLSI offices is 17 November 2005.
[
return to top ]
|